Comments and Opinion |
Public–private partnerships are collaborations between publicly funded organizations such as academic institutions and for-profit organizations such as pharmaceutical companies. They are often set up to benefit from complementary assets of each party, such as expertise in disease biology in academic institutions and expertise and financial resources for clinical development in companies.
News and Comment
- Nature Biotechnology 35, 117–118
News |Nature Biotechnology 33, 436–437
Research Highlights |Nature Reviews Drug Discovery 14, 238